Results 111 to 120 of about 6,068,920 (318)

Health Values, Preference Inconsistency, and Insurance Demand [PDF]

open access: yes
Several empirical studies provide evidence that their actual health state affects people’s attitudes towards health and medical care in hypothetical health states.
Matthias Wrede
core  

Impact of extended insurance coverage on survival outcomes among patients with metastatic colorectal cancer in Taiwan

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Predetermined treatment duration limits (PTDLs) are often used by Taiwan's National Health Insurance Administration to contain healthcare costs, but they may compromise patient outcomes. Therefore, we studied Taiwan's 2017 extension of the bevacizumab PTDL from 24 to 36 weeks in metastatic colorectal cancer (mCRC) to evaluate whether prolonged ...
Wei‐Ming Huang   +6 more
wiley   +1 more source

Determine of cost drivers in Activity Based Costing method of hospital services

open access: yesپژوهش‌های سلامت‌محور, 2019
Determination of Cost Drivers through Activity Based Costing Method in Determination of Hospital Services Costs  Meshkani Zahra1, Reza Pour Aziz2, Alipour Vahid3, Farabi Hero1*, Mazdaki Alireza4, Hakimi Narges5 1. Ph.D.
Zahra Meshkani   +5 more
doaj  

THE RANDOM ITERATION ALGORITHM [PDF]

open access: yes
In the last decades, many researchers concerned their attention on fractals properties of objects. Fractals can be use to describe natural shapes so their applications are various in many fields such as informatics, economics, engineering, medical ...
Daniela Alexandra CRIŞAN   +1 more
core  

Evidence to support integrating feedback best practice for computer‐based assessment in pharmacology education

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Feedback is the most powerful driver of learning, but it can afford variable effects depending on the method used. The design of feedback for computer‐based assessment—now increasingly prevalent in higher education—remains relatively underexplored, particularly for pharmacology education.
Claire Y. Hepburn
wiley   +1 more source

The development of day surgery in China and the effectiveness and reflection of day surgery in ophthalmology-specialized hospitals

open access: yesCost Effectiveness and Resource Allocation
This survey investigates the development of day surgery in China, and analyzes the national policy support, medical service management model, disease types of day surgery, medical insurance payment methods, and the medical service capacity, efficiency ...
Dong Haihan   +5 more
doaj   +1 more source

Dental Tourism in Moldova: Economic Catalyst, Medical Considerations, and Broader Tourism Development Potential

open access: yesTourism and Hospitality
This paper examines the burgeoning dental tourism sector in the Republic of Moldova, highlighting its significant economic impact and patient-related considerations. Driven primarily by competitive pricing, the perceived quality of dental treatments, and
Elisabetta Lazzari, Edoardo Bianco
doaj   +1 more source

How the HTAR will contribute to a value‐based decision‐making for medicinal products across the EU

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
The European Union Health Technology Regulation 2021/2282 (HTAR) introduces joint assessment of health technologies (including medicinal products and medical devices) across EU Member States. It was signed into law in 2021 and came into full force in January 2025.
Roisin Adams, Michal Stanak
wiley   +1 more source

Sample selection correction in panel data models when selectivity is due to two sources [PDF]

open access: yes
This paper proposes a specification of Wooldridge's (1995) two step estimation method in which selectivity bias is due to two sources rather than one. The main objective of the paper is to show how the method can be applied in practice.
Di Novi, Cinzia
core  

Through the lens of marketing authorization holders: experience in use of real‐world data and real‐world evidence in drug development and regulatory submissions in EU

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this study was to assess the general and product‐specific experiences of MAHs use of RWD/RWE in medicines development and in their regulatory submissions, and to explore organizational aspects of MAHs related to RWD/RWE. Methods An electronic survey was conducted, and information collected directly from MAHs.
Sini M. Eskola   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy